Skip to main content

Nanox to Report Third Quarter 2026 Financial Results on November 25, 2026

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PETACH TIKVA, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), a leader in innovative medical imaging technology, today announced that it will report its financial results for the quarter ended September 30, 2026, before market open on Wednesday, November 25, 2026. Erez Meltzer, Chief Executive Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link: Nanox Q3 2026 Conference Call

The live webcast of the conference call may be accessed by using the following link: Nanox Q3 2026 Webcast 

The webcast link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. 

About Nanox

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.

Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.

Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

The Nanox ecosystem includes Nanox.ARC X, a multi-source digital tomosynthesis system designed to make advanced 3D imaging accessible in more clinical settings; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provides access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

The Nanox.ARC X was selected as one of TIME’s Best Inventions of 2026.

TIME Best Inventions 2026

By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit https://www.nanox.vision.

Contacts

Media Contact:
Ben Shannon
ICR Healthcare
NanoxPR@icrinc.com

Investor Contact:
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/844b62ef-5cc4-444d-a707-a0262cbd1373


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.75
+0.00 (0.00%)
AAPL  352.78
+0.00 (0.00%)
AMD  504.28
+0.00 (0.00%)
BAC  50.08
+0.00 (0.00%)
GOOG  281.26
+0.00 (0.00%)
META  626.41
+0.00 (0.00%)
MSFT  517.99
+0.00 (0.00%)
NVDA  156.14
+0.00 (0.00%)
ORCL  119.09
+0.00 (0.00%)
TSLA  379.74
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.